newdrugapprovals.org
Pfizer’s Xalkori Granted Regular FDA Approval
Pfizer’s XALKORI® Granted Regular FDA Approval Standard of Care for Patients With Metastatic ALK-Positive Non-Small Cell Lung CancerNEW YORK, November 21, 2013–(BUSINESS WIRE)–Pfizer In…